Cytrix: Driving Organoid Research Forward
Cytrix provides a comprehensive portfolio of organoid products designed to advance both basic and translational research. Our 3D-ready organoid models, derived from healthy tissue, Induced Pluripotent Stem Cells (iPSCs), patient samples, and selected animal sources, covering a wide range of organs including liver, lung, brain, colon, pancreas, and breast. These models recapitulate key aspects of native tissue architecture, maintain key genomic features over passages under defined conditions, and patient-derived models retain disease-relevant phenotype, making them powerful systems for studying human development, disease mechanisms, drug response, and precision medicine applications.
To support reliable organoid establishment and long-term growth, we supply a full range of media and reagents, including culture media, basement membranes matrix, growth factors, and culture plates, all support robust expansion and controlled differentiation. Complementing these are organoid-validated antibodies targeting key lineage, immune, and tumor-associated markers, rigorously validated across applications such as IHC, IF, WB, and flow cytometry to provide high-confidence results.
Beyond models and reagents, Cytrix also delivers a range of services that broaden the possibilities of organoid research. All our products and services are supported by stringent quality control measures to ensure consistency, reliability, and scientific rigor across every stage of research.
With a portfolio that unites organoid models, culture systems, antibodies, and advanced services, Cytrix equips researchers with the tools and confidence to generate reproducible, clinically relevant insights and to accelerate the journey from discovery to therapeutic innovation.
Product Features
-
Diverse Origins
Organoid models derived from ASCs, iPSCs, or tissues, including both healthy and disease-specific samples.
-
Physiological Relevance
Organoids maintain native tissue architecture and functional properties that closely mimic in vivo conditions.
-
Long-Term Stability
Demonstrated genetic and phenotypic stability across extended culture periods, ensuring reproducibility.
Showing 64–72 of 106 results
Recombinant Human FGF-4 Protein, Tag-Free
Molecular Weight14.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human FGF-8a Protein, Tag-Free
Molecular Weight21.3 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human FGF-10 Protein, Tag-Free
Molecular Weight17.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human GDNF Protein, Tag-Free
Molecular Weight30.4 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human HGF NK1 Protein, Tag-Free
Molecular Weight20.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human IGF-1 Protein, Tag-Free
Molecular Weight8.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human Noggin Protein, Tag-Free
Molecular Weight46.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Mouse Noggin Protein, Tag-Free
Molecular Weight46.0 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
Recombinant Human NRG-1Protein, Tag-Free
Molecular Weight7.5 kDa
EndotoxinLess than 0.1 EU per μg by the LAL method / rFC method.
Expression SystemE. coli cells
No matching products.
Whether you're exploring disease mechanisms or screening novel therapeutics, Cytrix is your trusted partner.
Let's build the future of gut research together.
